Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease
Open accessPublished version of a preprint
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn’s disease, affect several million individuals worldwide. These diseases are heterogeneous at the clinical, immunological and genetic levels and result from complex host and environmental interactions. Investigating drug efficacy for IBD can improve our understanding of why treatment response can vary between patients. We propose an explainable machine learning (ML) approach that combines bioinformatics and domain insight, to integrate multi-modal data and predict inter-patient variation in drug response. Using explanation of our models, we interpret the ML models’ predictions to infer unique combinations of important features associated with pharmacological responses obtained during preclinical testing of drug candidates in ex vivo patient-derived fresh tissues. Our inferred multi-modal features that are predictive of drug efficacy include multi-omic data (genomic and transcriptomic), demographic, medicinal and pharmacological data. Our aim is to understand variation in patient responses before a drug candidate moves forward to clinical trials. As a pharmacological measure of drug efficacy, we measured the reduction in the release of the inflammatory cytokine TNFα from the fresh IBD tissues in the presence/absence of test drugs. We initially explored the effects of a mitogen-activated protein kinase (MAPK) inhibitor; however, we later showed our approach can be applied to other targets, test drugs or mechanisms of interest. Our best model predicted TNFα levels from demographic, medicinal and genomic features with an error of only 4.98% on unseen patients. We incorporated transcriptomic data to validate insights from genomic features. Our results showed variations in drug effectiveness (measured by ex vivo assays) between patients that differed in gender, age or condition and linked new genetic polymorphisms to patient response variation to the anti-inflammatory treatment BIRB796 (Doramapimod). Our approach models IBD drug response while also identifying its most predictive features as part of a transparent ML precision medicine strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AI's potential extends further, integrating diverse data types from IBD datasets, including clinical, endoscopic, histologic, and OMICs, enabling a multi-parametric analysis that can further enhance the quality of clinical trial outcomes towards precision medicine.78”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · cited 1×
“10 [48] and duplicate removal was performed using MarkDuplicates v2.”
MethodCortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421 · cited 1×
“We evaluated the application of five state-of-art machine learning models; random forest (RF) [52], XGBoost [53], Support Vector Machines (SVM) [54], K-Nearest Neighbors (KNN) [55] and Adaboost [56].”
XGBoost: A Scalable Tree Boosting System
Chen, T., & Guestrin, C. (2016) · Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining · doi:10.1145/2939672.2939785 · Cited by 54,569 · cited 3×
“We evaluated the application of five state-of-art machine learning models; random forest (RF) [52], XGBoost [53], Support Vector Machines (SVM) [54], K-Nearest Neighbors (KNN) [55] and Adaboost [56].”
MethodInfluentialRobinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“Gene expression levels were quantified using StringTie [50] and the raw expression counts per gene, were subsequently normalised across the 14 patients using EdgeR to generate TMM values [51].”
MethodA Unified Approach to Interpreting Model Predictions
Lundberg, S., & Lee, S.-I. (2017) · arXiv · doi:10.48550/arxiv.1705.07874 · Cited by 23,707
Gauriat, C.-M., Pencolé, Y., Ribot, P., & Brouillet, G. (2024) · HAL (Le Centre pour la Communication Scientifique Directe) · doi:10.4230/oasics.dx.2024.27 · Cited by 12,586
Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown
Pertea, M., Kim, D., Pertea, G. M., Leek, J. T., & Salzberg, S. L. (2016) · Nature Protocols · doi:10.1038/nprot.2016.095 · Cited by 6,845 · cited 1×
“Gene expression levels were quantified using StringTie [50] and the raw expression counts per gene, were subsequently normalised across the 14 patients using EdgeR to generate TMM values [51].”
MethodAn Introduction to Kernel and Nearest-Neighbor Nonparametric Regression
Altman, N. S. (1992) · The American Statistician · doi:10.1080/00031305.1992.10475879 · Cited by 5,708 · cited 1×
“We evaluated the application of five state-of-art machine learning models; random forest (RF) [52], XGBoost [53], Support Vector Machines (SVM) [54], K-Nearest Neighbors (KNN) [55] and Adaboost [56].”
MethodHo, T. K. (2002) · Proceedings of 3rd International Conference on Document Analysis and Recognition · doi:10.1109/icdar.1995.598994 · Cited by 5,054
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 1×
“, during or after demographic trials, comes with an associated high-cost burden, with approximately 70% of the cost of drug development attributed to the clinical stage [3].”
BackgroundAlatab, S., Sepanlou, S. G., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M. R., Abdoli, A., Abolhassani, H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30333-4 · Cited by 2,313
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · cited 1×
“TNF α is powerful proinflammatory cytokine that is a key mediator in inflammatory diseases [17].”
BackgroundMechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757 · cited 1×
“The most widely held hypothesis on the pathogenesis of IBD is that overly aggressive acquired (T cell) immune responses to a subset of commensal enteric bacteria develop in genetically susceptible hosts, and environmental factors precipitate the onset or reactivation of disease [9].”
BackgroundSynonymous but not the same: the causes and consequences of codon bias
Plotkin, J. B., & Kudla, G. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2899 · Cited by 1,685 · cited 1×
“, altering transcription and splicing regulatory factors within protein coding regions [40], thus potentially modulating gene expression.”
BackgroundLessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344
Codon Optimality Is a Major Determinant of mRNA Stability
Presnyak, V., Alhusaini, N., Chen, Y.-H., Martin, S., Morris, N., Kline, N., Olson, S., Weinberg, D., Baker, K. E., Graveley, B. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.029 · Cited by 1,078 · cited 1×
“Many of these SNPs were synonymous SNPs that do not change amino acids but can disrupt transcription [36], splicing [37], co-translational folding [38], mRNA stability [39], and cause a plethora of other functionally relevant changes e.”
BackgroundSchapire, R. E. (2013) · Empirical Inference · doi:10.1007/978-3-642-41136-6_5 · Cited by 1,013 · cited 3×
“We evaluated the application of five state-of-art machine learning models; random forest (RF) [52], XGBoost [53], Support Vector Machines (SVM) [54], K-Nearest Neighbors (KNN) [55] and Adaboost [56].”
MethodInfluentialMorgan, P., Van Der Graaf, P. H., Arrowsmith, J., Feltner, D. E., Drummond, K. S., Wegner, C. D., & Street, S. D. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.020 · Cited by 692
Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., Metzger, D., Wahli, W., Desvergne, B., Naccari, G. C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041948 · Cited by 526 · cited 5×
“The mechanisms of action of 5-ASA, prednisolone and BIRB796 have all been shown to interact with TNFα signalling via peroxisome proliferator-activated receptor gamma (PPARγ) [14], nuclear factor kappa light chain enhancer of activated B cells (NF-κB) [15] and mitogen activated protein kinase (MAPK) [16], respectively.”
BackgroundInfluentialMurch, S. H., Braegger, C. P., Walker-Smith, J. A., & MacDonald, T. T. (1993) · Gut · doi:10.1136/gut.34.12.1705 · Cited by 520
Evolutionary conservation of codon optimality reveals hidden signatures of cotranslational folding
Pechmann, S., & Frydman, J. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2466 · Cited by 495 · cited 1×
“Many of these SNPs were synonymous SNPs that do not change amino acids but can disrupt transcription [36], splicing [37], co-translational folding [38], mRNA stability [39], and cause a plethora of other functionally relevant changes e.”
BackgroundIrusen, E., Matthews, J. G., Takahashi, A., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122465 · Cited by 416 · cited 1×
“Phosphorylation of p38 MAPK has been shown to phosphorylate the glucocorticoid receptor and therefore downregulate its activity [35].”
BackgroundCho, S.-G., Lee, Y. H., Park, H.-S., Ryoo, K., Kang, K. W., Park, J., Eom, S.-J., Kim, M. J., Chang, T.-S., Choi, S.-Y., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005561200 · Cited by 400 · cited 2×
“Stress triggers, such as pro-inflammatory cytokines, have been shown to promote the dissociation of GST-M1 from ASK-1, thus activating p38 MAPK [30].”
BackgroundA role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn’s disease
Plevy, S. E., Landers, C. J., Prehn, J., Carramanzana, N. M., Deem, R. L., Shealy, D., & Targan, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.6276 · Cited by 385 · cited 1×
“The mechanism of action of Asacol (5-ASA) is not fully understood; however, some of its biological activity in IBD has been attributed to it being a PPARγ ligand [18].”
BackgroundBIRB796 Inhibits All p38 MAPK Isoforms in Vitro and in Vivo
Kuma, Y., Sabio, G., Bain, J., Shpiro, N., Márquez, R., & Cuenda, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414221200 · Cited by 304 · cited 16×
“Stress triggers, such as pro-inflammatory cytokines, have been shown to promote the dissociation of GST-M1 from ASK-1, thus activating p38 MAPK [30].”
BackgroundInfluentialExonic Transcription Factor Binding Directs Codon Choice and Affects Protein Evolution
Stergachis, A. B., Haugen, E., Shafer, A., Fu, W., Vernot, B., Reynolds, A., Raubitschek, A., Ziegler, S., LeProust, E. M., Akey, J. M., et al. (2013) · Science · doi:10.1126/science.1243490 · Cited by 288
Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools
Nicora, G., Vitali, F., Dagliati, A., Geifman, N., & Bellazzi, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01030 · Cited by 284
Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution
Pagani, F., Raponi, M., & Baralle, F. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502288102 · Cited by 246 · cited 1×
“Many of these SNPs were synonymous SNPs that do not change amino acids but can disrupt transcription [36], splicing [37], co-translational folding [38], mRNA stability [39], and cause a plethora of other functionally relevant changes e.”
BackgroundDubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J., & Desreumaux, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11395-x · Cited by 198 · cited 1×
“PPARγ, when activated, acts as a negative regulator of JNK/p38 MAPK signalling [31], both of which BIRB796 is a direct inhibitor of [20].”
BackgroundOlsen, T., Goll, R., Cui, G., Husebekk, A., Vonen, B., Birketvedt, G. S., & Florholmen, J. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701409035 · Cited by 154
BLIMP-1: trigger for differentiation of myeloid lineage
Chang, D., Angelin‐Duclos, C., & Calame, K. L. (2000) · Nature Immunology · doi:10.1038/77861 · Cited by 150 · cited 1×
“BLIMP-1 (the protein encoded by PRDM1) is thought to be critical to the maintenance of immune homeostasis [44] and p38 MAPK has been shown to be a positive upstream regulator of BLIMP-1 expression [45].”
BackgroundThe Importance of the Circadian Clock in Regulating Plant Metabolism
Kim, J., Kim, H.-S., Choi, S.-H., Jang, J.-Y., Jeong, M.-J., & Lee, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122680 · Cited by 117
Quantifying factors for the success of stratified medicine
Trusheim, M. R., Burgess, B., Hu, S. X., Long, T. W., Averbuch, S. D., Flynn, A. A., Lieftucht, A., Mazumder, A., Milloy, J., Shaw, P. M., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3557 · Cited by 116
Challenges in IBD Research: Precision Medicine
Denson, L. A., Curran, M., McGovern, D. P. B., Koltun, W. A., Duerr, R. H., Kim, S. C., Sartor, R. B., Sylvester, F. A., Abraham, C., de Zoeten, E. F., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz078 · Cited by 94
Explainable AI reveals changes in skin microbiome composition linked to phenotypic differences
Carrieri, A. P., Haiminen, N., Maudsley-Barton, S., Gardiner, L.-J., Murphy, B., Mayes, A. E., Paterson, S., Grimshaw, S., Winn, M., Shand, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83922-6 · Cited by 94 · cited 1×
“Only recently has explainable AI been applied to diverse single omic datasets [24, 25], but the potential of this to enable precision medicine has yet to be fully exploited.”
BackgroundSelf-citationPerspective: Does personalized medicine hold the future for medicine?
Agyeman, A., & Ofori‐Asenso, R. (2015) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.160040 · Cited by 84
Stocco, G., Martelossi, S., Barabino, A. V., Decorti, G., Bartoli, F., Montico, M., Gotti, A., & Ventura, A. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20004 · Cited by 83
NF-κB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms
Nelson, G., Wilde, G. J. C., Spiller, D. G., Kennedy, S. M., Ray, D. W., Sullivan, E., Unitt, J. F., & White, M. R. H. (2003) · Journal of Cell Science · doi:10.1242/jcs.00461 · Cited by 78 · cited 2×
“The mechanisms of action of 5-ASA, prednisolone and BIRB796 have all been shown to interact with TNFα signalling via peroxisome proliferator-activated receptor gamma (PPARγ) [14], nuclear factor kappa light chain enhancer of activated B cells (NF-κB) [15] and mitogen activated protein kinase (MAPK) [16], respectively.”
BackgroundKumar, M., Garand, M., & Al Khodor, S. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02174-1 · Cited by 75 · cited 1×
“As such, we need to understand why certain medications are more or less effective for different patients and relate this to their demographic information and genetic makeup [10].”
BackgroundGenomic Medicine, Precision Medicine, Personalized Medicine: What’s in a Name?
Roden, D. M., & Tyndale, R. F. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.101 · Cited by 72
In Sickness and in Health: The Role of TRAPP and Associated Proteins in Disease
Brunet, S., & Sacher, M. G. (2014) · Traffic · doi:10.1111/tra.12183 · Cited by 52 · cited 1×
“TRAPPC9 demonstrating an ability (with NIBP) to potentiate TNFα-induced activation [42] and GRM6 encodes a glutamate receptor which has significance since it has been reported that peripheral glutamate and peripheral glutamate receptors contribute to inflammatory pain [43].”
BackgroundP38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells
Lea, S., Li, J., Plumb, J., Gaffey, K., Mason, S., Gaskell, R., Harbron, C. G., & Singh, D. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01873-3 · Cited by 45 · cited 1×
“Glucocorticoid signalling has been closely linked to MAPK signalling pathways, with p38 MAPK shown to play a key role in the expression and sensitivity of glucocorticoid receptors to ligands [34].”
BackgroundChen, Y., Guzauskas, G. F., Gu, C., Wang, B., Furnback, W. E., Xie, G., Dong, P., & Garrison, L. P. (2016) · Journal of Personalized Medicine · doi:10.3390/jpm6040020 · Cited by 44 · cited 1×
“Precision medicine has become a widely recognised and desirable medical model for its ability to stratify patients into different groups based on their susceptibility to a particular disease or their response to a specific drug [1].”
BackgroundGardiner, L., Rusholme‐Pilcher, R., Colmer, J., Rees, H., Crescente, J. M., Carrieri, A. P., Duncan, S. H., Pyzer‐Knapp, E. O., Krishna, R., & Hall, A. J. W. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103070118 · Cited by 29 · cited 1×
“Only recently has explainable AI been applied to diverse single omic datasets [24, 25], but the potential of this to enable precision medicine has yet to be fully exploited.”
BackgroundSelf-citationGlutathione Transferases in the Bioactivation of Azathioprine
Modén, O., & Mannervik, B. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-420117-0.00006-2 · Cited by 27 · cited 1×
“The enzyme GST-M1 is involved in the metabolism of azathioprine [27].”
BackgroundGaleotti, N., & Ghelardini, C. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.020 · Cited by 26 · cited 1×
“Although less characterised in IBD, PKCε has been shown to be an upstream regulator of p38 MAPK in rat models of stress and anxiety [32].”
BackgroundAll-Comers versus Enrichment Design Strategy in Phase II Trials
Mandrekar, S. J., & Sargent, D. J. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820e17cb · Cited by 23 · cited 1×
“To investigate whether patient stratification could be achieved from a preclinical study, the commonly used ‘all comers’ clinical trial patient recruitment policy was mimicked with no donor inclusion criteria other than a clinical diagnosis of UC or Crohn’s, as confirmed by a clinical pathologist [11].”
MethodMorampudi, V., Conlin, V. S., Dalwadi, U., Wu, X., Marshall, K. C., Nguyen, C. P., Vallance, B. A., & Jacobson, K. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00195.2014 · Cited by 22 · cited 1×
“PKCε has also been shown to be a key signalling molecule in the development of bacterial pathogen-induced colitis in human intestinal lineage Caco-2 cell monolayers [33].”
BackgroundLucafò, M., Stocco, G., Martelossi, S., Favretto, D., Franca, R., Malusà, N., Lora, A., Bramuzzo, M., Naviglio, S., Cecchin, E., et al. (2019) · Genes · doi:10.3390/genes10040277 · Cited by 16
Chang, H., Huang, D.-Y., Wu, N., Kannagi, R., Wang, L., & Lin, W. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.08.011 · Cited by 10 · cited 1×
“BLIMP-1 (the protein encoded by PRDM1) is thought to be critical to the maintenance of immune homeostasis [44] and p38 MAPK has been shown to be a positive upstream regulator of BLIMP-1 expression [45].”
BackgroundLee, S. H., Kwon, N. S., Baek, K. J., Yun, H., & Kim, D. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154872 · Cited by 7 · cited 2×
“Investigation of these genes rationalised their prioritization by the ML model for prediction or discrimination of inflammatory response between patients; TLX1 is linked to colorectal adenocarcinoma that chronic or poorer prognosis IBD patients are known to have a higher risk of developing, ADAM22 has been implicated…”
BackgroundGardiner, L., Rusholme-Pilcher, R. L., Colmer, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.04.429826 · Cited by 6
Self-citationCowan, K., Macluskie, G., Finch, M., Palmer, C. N. A., Hair, J., Bylesjö, M., Lynagh, S., Brankin, P., McNeil, M., Low, C., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226564 · Cited by 3
Self-citationInflammation, Role of Peripheral Glutamate Receptors
Carlton, S. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-28753-4_1945 · Cited by 1
Research works printed but not linked: 1
- S.M. Carlton, 2013, Encyclopedia of Pain
Cited by
Role of protein phosphorylation in cell signaling, disease, and the intervention therapy
Pang, K., Wang, W., Qin, J., Shi, Z., Hao, L., Ma, Y., Xu, H., Wu, Z., Pan, D., Chen, Z., et al. (2022) · MedComm · doi:10.1002/mco2.175 · Cited by 179
Sel, K., Hawkins-Daarud, A. J., Chaudhuri, A., Osman, D., Bahai, A. R. S., Paydarfar, D., Willcox, K. E., Chung, C., & Jafari, R. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01447-y · Cited by 179
Iacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00053-0 · Cited by 73
Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
Fiocchi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914912 · Cited by 67
Cannarozzi, A. L., Latiano, A., Massimino, L., Bossa, F., Giuliani, F., Riva, M., Ungaro, F., Guerra, M., Brina, A. L. D., Biscaglia, G., et al. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12655 · Cited by 65
Metadata
- Authors
- Gardiner, L.-J., Carrieri, A. P., Bingham, K., Macluskie, G., Bunton, D., McNeil, M., & Pyzer-Knapp, E. O.
- Affiliations
- Sci-Tech Daresbury (GB)
- ReproCELL (United Kingdom) (GB)
- Queen Elizabeth University Hospital (GB)
- Corresponding author
- Gardiner, Laura-Jayne
- Carrieri, Anna Paola
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-02-23
- Volume
- 17
- Issue
- 2
- Pages
- e0263248
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8865677
- OpenAlex
- W4213237113
- Cited by
- 36
- References
- 53
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 2
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Science and Technology Facilities Council (submittedVersion, cc-by)
- Funders
- UK Research and Innovation (Hartree National Centre for Digital Innovation)
- Scottish Funding Council (Precision Medicine Scotland Innovation Centre (PMS-IC))
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, precision medicine, explainable machine learning, drug response prediction, interpatient variability, multi-omics integration, MAPK inhibitors, genetic polymorphism, transcriptomics, demographic predictors, precision dosing
- MeSH terms
- Machine Learning, Adolescent, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Colitis, Ulcerative, Crohn Disease, Drug Evaluation, Preclinical, Female, Humans, Male, Middle Aged, Naphthalenes, Phenylurea Compounds, Prednisolone, Pyrazoles, Tumor Necrosis Factor-alpha, Signal Transduction, Mesalamine, Genomics, Young Adult, Precision Medicine, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.